Junying Yu

Junying Yu was born in 1975 in Zhejiang, China. Yu graduated from the Department of Biology of Perking University in China. In 2003, she then traveled to the United States so she could continue studying and obtain her PhD from the University of Pennsylvania. Junying Yu is an assistant scientist with the University of Wisconsin-Madison Primate Research Center and the Genome Center of Wisconsin. Yu is the author of a paper describing a novel method of reprogramming adult stem cells to create cells that are indistinguishable from embryonic stem cells. Yu is currenty still alive.

Junying Yu

Biography

References-http://www.news.wisc.edu/newsphotos/stemcells2007.html-http://www.zoominfo.com/p/Junying-Yu/1236195541-http://stemcells.nih.gov/info/Regenerative_Medicine/pages/2006chapter1.aspx

Junying Yu and her colleagues have faced problems with right wing activists and anti-abortionists for their research with embryonic stem cells. The research has been called inhumane and that they are taking the lives of babies that will never be born. Yu has also faced Social struggles when she decided she wanted to move into the United States since she spoke chinese instead of English.

Yu has had 26 publications and 2151 citations since 2003. One of her publications was on somatic coding mutations in human induced pluripotent stem cells. (capable of giving rise to several different cell types). Yu's research has not concluded but can lead to multiple cures for diseases such as Parkinson's and Acute Undifferentiated Leukemia.

Scientific contributions

Social struggles

By:Zachery B. Simpson

Your paragraph here

Summation

The effect that Junying Yu has had on a global scale could one day be massive. Her research could lead to a cure for more than 80 dieseases including Acute Undifferentiated Leukemia and Parkinson's. She is currently a key leader in developing the method of reprogramming pluripotent stem cells. Her research has been applied to curing mice with Parkinson's but has not been tested on humans. The mice have shown the statistics of a 20% mortality rate. Yu and her team are still researching these methods and other methods of applying stem cells to create differentiated cells. Stem cells could live indefinitely but as embryonic stem cells age, they could lead to different forms of Leukemia after going through cell differentiation.